Iesha Iwobi
Physician Assistant · Chico, CANPI 1750041265
Payments from drug & device makers
Across 169 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$525
- Alkermes, Inc.$401
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$365
- Neurocrine Biosciences, Inc.$317
- Otsuka America Pharmaceutical, Inc.$315
- Teva Pharmaceuticals USA, Inc.$308
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,22093%
- Education$2387%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $525 |
| Alkermes, Inc. | 23 | $401 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $365 |
| Neurocrine Biosciences, Inc. | 16 | $317 |
| Otsuka America Pharmaceutical, Inc. | 10 | $315 |
| Teva Pharmaceuticals USA, Inc. | 6 | $308 |
| Johnson & Johnson(2 entities) | 9 | $259 |
| Novo Nordisk | 7 | $163 |
| Indivior Inc. | 6 | $117 |
| Axsome Therapeutics, Inc. | 4 | $88 |
| Almatica Pharma LLC | 4 | $87 |
| Pfizer | 3 | $75 |
| Dexcom, Inc. | 3 | $69 |
| Lilly USA, LLC | 3 | $44 |
| Corium, LLC | 2 | $42 |
| Bayer | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
| Exact Sciences | 2 | $28 |
| Corcept Therapeutics | 1 | $23 |
| Vertex | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Merck | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Alk-abello, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$121
- VRAYLAR$118
- Austedo XR$111
How this compares
$3,458 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 14 | $105,802 |
| Invega SustennaPaliperidone Palmitate | 32 | $104,775 |
| VraylarCariprazine Hcl | 57 | $89,147 |
| RexultiBrexpiprazole | 46 | $67,170 |
| Lurasidone Hcl | 140 | $46,694 |
| CaplytaLumateperone Tosylate | 22 | $44,982 |
| FanaptIloperidone | 11 | $12,701 |
| Divalproex Sodium ErDivalproex Sodium | 66 | $8,344 |
| Quetiapine Fumarate | 144 | $4,620 |
| Oxcarbazepine | 62 | $3,906 |
| Aripiprazole | 60 | $3,621 |
| Olanzapine | 68 | $2,994 |
| Fluvoxamine Maleate | 40 | $2,380 |
| Trazodone Hcl | 197 | $2,299 |
| Fluoxetine Hcl | 119 | $2,266 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $317 | $105,80214 claims |
| Johnson & JohnsonInvega Sustenna | $259 | $104,77532 claims |
| AbbVieVraylar | $525 | $89,14757 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $315 | $67,17046 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $365 | $44,98222 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $31 | $12,70111 claims |
| Lilly USA, LLCOlanzapine | $44 | $2,99468 claims |
| Almatica Pharma LLCSertraline Hcl | $87 | $906123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Chico
- Omar OnChico$63K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.